About Larry Weiner
Form D filings for Sunflower Therapeutics, PBC from 2022 to 2024 list Larry Weiner as director.
Larry Weiner first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Larry Weiner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Larry Weiner works with at each company, as listed on that company's latest Form D.
Sunflower Therapeutics, PBC · Form D, May 24, 2024